Skip to Content

Havn Life Sciences

(CSE:HAVN)

Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research.
The company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds.
The company’s research facility is located on the South Campus at The University of British Columbia (UBC).

Headlines

teathers app screenshot

App Empowering Private Investors

Crowd Equity for Placings, IPOs and Live Market Blockbuilds, designed to give provate investors access to placements and Intial Public Offerings (IPOs), predominantly on the London Stock Exchange’s Alternative Investment Market (AIM).